Ep188: Art Krieg on Innate Immune System Activators for Cancer
Art Krieg, founder and CEO of Zola Therapeutics, …
The Long Run with Luke Timmerman · Timmerman Report
October 28, 20251h 9m
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.